​

ADARx Pharmaceuticals (ADRX) Revenue & Revenue Breakdown


OverviewFinancialsChart

ADARx Pharmaceuticals Revenue Highlights


Latest Revenue (Y)

$3.45M

Latest Revenue (Q)

$2.22M

ADARx Pharmaceuticals Revenue by Period


ADARx Pharmaceuticals Revenue by Year

DateRevenueChange
2025-12-31$3.45M-

ADARx Pharmaceuticals generated $3.45M in revenue during NA 2025, up 0.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

ADARx Pharmaceuticals Revenue by Quarter

DateRevenueChange
2026-09-30$2.22M197.18%
2026-06-30$746.00K-65.14%
2026-03-31$2.14M32.06%
2025-12-31$1.62M-

ADARx Pharmaceuticals generated $2.22M in revenue during Q3 2026, up 197.18% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

ADARx Pharmaceuticals Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
STOKStoke Therapeutics$184.42M$11.26M
ARCTArcturus Therapeutics$82.03M$18.30M
WVEWave Life Sciences$42.73M$13.16M
MGTXMeiraGTx$33.28M$4.81M
RNAAtrium Therapeutics$18.75M$15.32M
PRQRProQR Therapeutics$6.38M$4.48M
PRMEPrime Medicine$4.63M$4.21M
ADRXADARx Pharmaceuticals$3.45M$2.22M
SLNSilence Therapeutics$559.00K-
RNAZTransCode Therapeutics--
BNTCBenitec Biopharma--

ADRX Revenue FAQ


What is ADARx Pharmaceuticals’s yearly revenue?

ADARx Pharmaceuticals's yearly revenue for 2025 was $3.45M, representing an increase of 0% compared to 2024.

What is ADARx Pharmaceuticals’s quarterly revenue?

ADARx Pharmaceuticals's quarterly revenue for Q3 2026 was $2.22M, a 197.18% increase from the previous quarter (Q2 2026). The company's quarterly revenue for Q2 2026 was $746K, a -65.14% decrease from the previous quarter (Q1 2026). ADRX's quarterly revenue for Q1 2026 was $2.14M, a 32.06% increase from the previous quarter (Q4 2025).